Supreme Court Justices Question Role Of Comparative Safety Assessments In Vaccine Liability Case
This article was originally published in The Pink Sheet Daily
Executive Summary
In Bruesewitz v Wyeth oral arguments, high court weighs whether the National Childhood Vaccine Injury Act preempts all design defect claims against manufacturers.
You may also be interested in...
Supreme Court Immunizes Vaccine Manufacturers Against Design Defect Claims
In a 6-2 decision, the high court rules that manufacturers need not show that it would have been impossible to make a safer product and that plaintiffs' injuries were, therefore, unavoidable.
Supreme Court Immunizes Vaccine Manufacturers Against Design Defect Claims
In a 6-2 decision, the high court rules that manufacturers need not show that it would have been impossible to make a safer product and that plaintiffs' injuries were, therefore, unavoidable.
Vaccine Safety: Could More Outside Advisors For HHS Improve Public Perception?
An outside oversight group may be recommended to restore public confidence in vaccine safety, but several members of the National Vaccine Advisory Committee are not entirely sold that it is necessary.